Samantha Meltzer-Brody, MD, director, perinatal psychiatry program, University of North Carolina at Chapel Hill. “FDA approves first treatment for post-partum depression,” FDA News Release.
Brexanolone (Zulresso) is FDA-approved to treat postpartum depression, which puts mother and healthy child development at risk. Learn more.
Copyright © 2019 Bottom Line Inc. 3 Landmark Square Suite 201 Stamford, CT 06901
Bottom Line, Inc. publishes the opinions of expert authorities in many fields These opinions are for educational and illustrative purposes only and should not be considered as either individual advice or as a substitute for legal, accounting, investment, medical and other professional services intended to suit your specific personal needs. Always consult a competent professional for answers specific to your questions and circumstances. Our content is further subject to our Terms and Conditions